bell
The current prices are delayed by 15 mins, login to check live prices.
Hikal Ltd share price logo

Hikal Ltd

(HIKAL)

₹391.051.12%

as on 04:01PM, 22 Nov 2024

Overview
News
Financials
Q2 2024 Results
Technicals

Hikal Ltd Analyst Rating

based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts offering long term price targets for Hikal Ltd. An average target of ₹435

Source: S&P Global Market Intelligence

Hikal Ltd Share analysis

Hikal Ltd price forecast by 2 analysts

Upside of11.24%

High

₹450

Target

₹435.00

Low

₹420

Hikal Ltd target price ₹435, a slight upside of 11.24% compared to current price of ₹391.05. According to 2 analysts rating.

Source: S&P Global Market Intelligence

Hikal Ltd Performance

  • Day's Low

    Day's High

    ₹384.25
    ₹395
  • 52 Week's Low

    52 Week's High

    ₹260.3
    ₹416.95
1 Month Return+ 10 %
3 Month Return+ 19.51 %
1 Year Return+ 45.34 %
Previous Close₹386.70
Open₹386.80
Volume2.69L
Upper Circuit-
Lower Circuit-
Market Cap₹4,768.04Cr

Hikal Ltd Key Statistics

P/E Ratio65.61
PEG Ratio-96.49
Market Cap₹4,768.04 Cr
P/B Ratio2.75
EPS5.64
Dividend Yield0.45
SectorPharmaceuticals
ROE5.99

Hikal Ltd Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
BUY₹4,768.04 Cr52.69%0.72₹69 Cr₹1,784 Cr
HOLD₹32,443.03 Cr133.7%0.52₹300 Cr₹1,051 Cr
BUY₹18,006.48 Cr29.79%0.57₹72 Cr₹6,702 Cr
NA₹6,176.62 Cr3.81%0.79-₹388 Cr₹75 Cr
BUY₹15,982.20 Cr50.41%0.68₹218 Cr₹1,296 Cr

About Hikal Ltd

Hikal Limited is an Indian-based company, incorporated in 1988, with global recognition in the pharmaceutical, crop protection, animal health, biocides and specialty chemicals industries. It has 5 manufacturing facilities in 3 states, producing various chemical intermediates, active pharma ingredients, APIs and contract research activities. With their multiple partnerships and technological expansion projects, they have achieved milestones such as receiving the 5 Star Safety Award from the UK British Safety Council and their promotion to a trading house status. They have acquired an agrochemical manufacturing site from Novartis India Limited, which was followed by an investment in a JV with a Sinochem Corporation China subsidiary. Furthermore, they provide human and animal health products, amongst others. Recent developments such as the long-term contracts with life science companies, the sale of the RD unit and the bonus share issuance to shareholders indicate the company's success.

Share Price: ₹391.05 per share as on 22 Nov, 2024 04:01 PM
Market Capitalisation: ₹4,768.04Cr as of today
Revenue: ₹450.80Cr as on September 2024 (Q3 24)
Net Profit: ₹18.30Cr as on September 2024 (Q3 24)
Listing date: 14 Feb, 2001
Chairperson Name: Jai Hiremath
OrganisationHikal Ltd
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Hikal Ltd

  • Hikal Reports Strong Quarterly Performance and Growth - 13 Nov, 2024

    Hikal Ltd's Q2 FY25 revenue rose 4.14% YoY to ₹453 crore, with PAT increasing to ₹25 crore. Standalone net sales for September 2024 also showed growth, with a significant rise in profit. The stock surged due to strong quarterly performance.

Insights on Hikal Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 6.67% to 6.78% in Sep 2024 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 5.1 Cr → 18.3 Cr (in ₹), with an average increase of 72.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, HIKAL stock has moved up by 10.0%

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 407.3 Cr → 453.3 Cr (in ₹), with an average increase of 10.2% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 2.73% to 3.22% in Sep 2024 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 68.85% of holdings in Sep 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 128.6% return, outperforming this stock by 155.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 62.6% return, outperforming this stock by 17.3%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.32% to 20.79% in Sep 2024 quarter

Hikal Ltd Financials

Value in ₹ crore
DetailsQ'3 23Q'4 23Q'1 24Q'2 24Q'3 24
Revenue₹431.23Cr (-)₹438.54Cr (↑1.70%)₹512.80Cr (↑16.93%)₹403.80Cr (↓21.26%)₹450.80Cr (↑11.64%)
Net Income₹12.57Cr (-)₹16.14Cr (↑28.40%)₹33.90Cr (↑110.04%)₹5.10Cr (↓84.96%)₹18.30Cr (↑258.82%)
Net Profit Margin2.91% (-)3.68% (↑26.46%)6.61% (↑79.62%)1.26% (↓80.94%)4.06% (↑222.22%)
Value in ₹ crore
Details2021202220232024
Total Assets₹1,926.12Cr (-)₹2,213.12Cr (↑14.90%)₹2,400.52Cr (↑8.47%)₹2,504.30Cr (↑4.32%)
Total Liabilities₹992.70Cr (-)₹1,145.11Cr (↑15.35%)₹1,267.03Cr (↑10.65%)₹1,316.71Cr (↑3.92%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹284.93Cr (-)₹229.02Cr (↓19.62%)₹293.73Cr (↑28.26%)₹315.29Cr (↑7.34%)₹186.62Cr (↓40.81%)

Index Inclusions

BSE Healthcare

₹42,969.55

1.23 (522.48%)

S&P BSE AllCap

₹10,471.31

0.68 (71.07%)

BSE Small-Cap

₹52,612.93

0.9 (471.78%)

Hikal Ltd Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
68.85%
0.00
Foreign Institutions
6.78%
1.73
Mutual Funds
3.22%
17.85
Retail Investors
20.79%
-2.46
Others
0.36%
-17.97

Hikal Ltd Key Indicators

Details20202021202220232024
Earning Per Share (₹)6.8510.813.026.365.64
Details20202021202220232024
Return On Equity %12.0615.2216.047.125.99
Details20202021202220232024
Return On Assets %4.746.917.253.272.78
Details20202021202220232024
Book Value Per Share (₹)66.2275.786.6291.9396.32

Hikal Ltd Valuation

Hikal Ltd in the last 5 years

  • Overview

  • Trends

Lowest (8.33x)

March 24, 2020

Industry (54.77x)

November 22, 2024

Today (65.61x)

November 22, 2024

Highest (81.58x)

January 3, 2023

LowHigh

Hikal Ltd Earnings and Dividends

  • Hikal Ltd Earnings Results

    Hikal Ltd’s net profit jumped 45.58% since last year same period to ₹18.30Cr in the Q2 2024-2025. On a quarterly growth basis, Hikal Ltd has generated 258.82% jump in its net profits since last 3-months.

    Read More about Earnings Results
  • Hikal Ltd Dividends May,2024

    In the quarter ending March 2024, Hikal Ltd has declared dividend of ₹0.60 - translating a dividend yield of 0.46%.

    Read More about Dividends

Hikal Ltd Technicals Summary

Bearish

Neutral

Bullish

Bullish

Hikal Ltd is currently in a Bullish trading position according to technical analysis indicators.

FAQs on Hikal Ltd

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Hikal Ltd shares.

Hikal Ltd (HIKAL) share price today is ₹391.05

Hikal Ltd is listed on NSE

Hikal Ltd is listed on BSE

  • Today’s highest price of Hikal Ltd is ₹395.
  • Today’s lowest price of Hikal Ltd is ₹384.25.

PE Ratio of Hikal Ltd is 65.61

PE ratio = Hikal Ltd Market price per share / Hikal Ltd Earnings per share

Today’s traded volume of Hikal Ltd(HIKAL) is 2.69L.

Today’s market capitalisation of Hikal Ltd(HIKAL) is ₹4768.04Cr.

Hikal Ltd(HIKALPrice
52 Week High
₹416.95
52 Week Low
₹260.3

Hikal Ltd(HIKAL) share price is ₹391.05. It is down -6.21% from its 52 Week High price of ₹416.95

Hikal Ltd(HIKAL) share price is ₹391.05. It is up 50.23% from its 52 Week Low price of ₹260.3

Hikal Ltd(HIKALReturns
1 Day Returns
4.35%
1 Month Returns
10%
3 Month Returns
19.51%
1 Year Returns
45.34%